Logo image of CBRE

CBRE GROUP INC - A (CBRE) Stock Fundamental Analysis

NYSE:CBRE - US12504L1098 - Common Stock

162.12 USD
+0.13 (+0.08%)
Last: 8/29/2025, 8:10:12 PM
162.12 USD
0 (0%)
After Hours: 8/29/2025, 8:10:12 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CBRE. CBRE was compared to 65 industry peers in the Real Estate Management & Development industry. CBRE has only an average score on both its financial health and profitability. CBRE is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes CBRE very considerable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CBRE had positive earnings in the past year.
CBRE had a positive operating cash flow in the past year.
In the past 5 years CBRE has always been profitable.
In the past 5 years CBRE always reported a positive cash flow from operatings.
CBRE Yearly Net Income VS EBIT VS OCF VS FCFCBRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

The Return On Assets of CBRE (3.94%) is better than 87.69% of its industry peers.
CBRE has a Return On Equity of 13.21%. This is amongst the best in the industry. CBRE outperforms 95.38% of its industry peers.
With an excellent Return On Invested Capital value of 6.77%, CBRE belongs to the best of the industry, outperforming 87.69% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CBRE is in line with the industry average of 6.48%.
Industry RankSector Rank
ROA 3.94%
ROE 13.21%
ROIC 6.77%
ROA(3y)5.07%
ROA(5y)5.54%
ROE(3y)13.78%
ROE(5y)14.7%
ROIC(3y)7.46%
ROIC(5y)7.57%
CBRE Yearly ROA, ROE, ROICCBRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 2.86%, CBRE is in the better half of the industry, outperforming 72.31% of the companies in the same industry.
CBRE's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 4.26%, CBRE perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
CBRE's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 19.42%, CBRE perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
CBRE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.26%
PM (TTM) 2.86%
GM 19.42%
OM growth 3Y-8.91%
OM growth 5Y-5.18%
PM growth 3Y-25.78%
PM growth 5Y-12.79%
GM growth 3Y-4.04%
GM growth 5Y-2.06%
CBRE Yearly Profit, Operating, Gross MarginsCBRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

CBRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CBRE has less shares outstanding
The number of shares outstanding for CBRE has been reduced compared to 5 years ago.
Compared to 1 year ago, CBRE has a worse debt to assets ratio.
CBRE Yearly Shares OutstandingCBRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CBRE Yearly Total Debt VS Total AssetsCBRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

An Altman-Z score of 3.59 indicates that CBRE is not in any danger for bankruptcy at the moment.
The Altman-Z score of CBRE (3.59) is better than 78.46% of its industry peers.
CBRE has a debt to FCF ratio of 6.64. This is a slightly negative value and a sign of low solvency as CBRE would need 6.64 years to pay back of all of its debts.
CBRE's Debt to FCF ratio of 6.64 is fine compared to the rest of the industry. CBRE outperforms 70.77% of its industry peers.
CBRE has a Debt/Equity ratio of 0.88. This is a neutral value indicating CBRE is somewhat dependend on debt financing.
CBRE's Debt to Equity ratio of 0.88 is in line compared to the rest of the industry. CBRE outperforms 43.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 6.64
Altman-Z 3.59
ROIC/WACC0.71
WACC9.6%
CBRE Yearly LT Debt VS Equity VS FCFCBRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

CBRE has a Current Ratio of 1.13. This is a normal value and indicates that CBRE is financially healthy and should not expect problems in meeting its short term obligations.
CBRE's Current ratio of 1.13 is on the low side compared to the rest of the industry. CBRE is outperformed by 60.00% of its industry peers.
CBRE has a Quick Ratio of 1.13. This is a normal value and indicates that CBRE is financially healthy and should not expect problems in meeting its short term obligations.
CBRE has a worse Quick ratio (1.13) than 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.13
CBRE Yearly Current Assets VS Current LiabilitesCBRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

7

3. Growth

3.1 Past

CBRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.95%, which is quite impressive.
The Earnings Per Share has been growing slightly by 6.61% on average over the past years.
CBRE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.96%.
The Revenue has been growing by 8.40% on average over the past years. This is quite good.
EPS 1Y (TTM)50.95%
EPS 3Y-1.88%
EPS 5Y6.61%
EPS Q2Q%46.91%
Revenue 1Y (TTM)14.96%
Revenue growth 3Y8.83%
Revenue growth 5Y8.4%
Sales Q2Q%16.24%

3.2 Future

The Earnings Per Share is expected to grow by 18.49% on average over the next years. This is quite good.
CBRE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.64% yearly.
EPS Next Y21.9%
EPS Next 2Y20%
EPS Next 3Y18.89%
EPS Next 5Y18.49%
Revenue Next Year12.55%
Revenue Next 2Y11.32%
Revenue Next 3Y10.72%
Revenue Next 5Y8.64%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CBRE Yearly Revenue VS EstimatesCBRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B
CBRE Yearly EPS VS EstimatesCBRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 29.11, which means the current valuation is very expensive for CBRE.
78.46% of the companies in the same industry are more expensive than CBRE, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.13, CBRE is valued at the same level.
With a Price/Forward Earnings ratio of 22.03, CBRE is valued on the expensive side.
Based on the Price/Forward Earnings ratio, CBRE is valued cheaper than 83.08% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.76, CBRE is valued at the same level.
Industry RankSector Rank
PE 29.11
Fwd PE 22.03
CBRE Price Earnings VS Forward Price EarningsCBRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CBRE is valued a bit cheaper than the industry average as 69.23% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CBRE indicates a somewhat cheap valuation: CBRE is cheaper than 66.15% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 43.3
EV/EBITDA 21.99
CBRE Per share dataCBRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

CBRE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CBRE has a very decent profitability rating, which may justify a higher PE ratio.
CBRE's earnings are expected to grow with 18.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.33
PEG (5Y)4.4
EPS Next 2Y20%
EPS Next 3Y18.89%

0

5. Dividend

5.1 Amount

No dividends for CBRE!.
Industry RankSector Rank
Dividend Yield N/A

CBRE GROUP INC - A

NYSE:CBRE (8/29/2025, 8:10:12 PM)

After market: 162.12 0 (0%)

162.12

+0.13 (+0.08%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-22 2025-10-22/bmo
Inst Owners99.39%
Inst Owner Change-3.15%
Ins Owners0.52%
Ins Owner Change1.33%
Market Cap48.24B
Analysts81.05
Price Target166.27 (2.56%)
Short Float %1.35%
Short Ratio2.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.5%
Min EPS beat(2)8.58%
Max EPS beat(2)10.42%
EPS beat(4)4
Avg EPS beat(4)8.04%
Min EPS beat(4)2.25%
Max EPS beat(4)10.89%
EPS beat(8)8
Avg EPS beat(8)8.61%
EPS beat(12)11
Avg EPS beat(12)6.47%
EPS beat(16)14
Avg EPS beat(16)9.15%
Revenue beat(2)1
Avg Revenue beat(2)-0.41%
Min Revenue beat(2)-1.96%
Max Revenue beat(2)1.13%
Revenue beat(4)2
Avg Revenue beat(4)-0.24%
Min Revenue beat(4)-1.96%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)0.47%
Revenue beat(12)7
Avg Revenue beat(12)0.5%
Revenue beat(16)9
Avg Revenue beat(16)0.15%
PT rev (1m)7.66%
PT rev (3m)12.66%
EPS NQ rev (1m)0.63%
EPS NQ rev (3m)1.73%
EPS NY rev (1m)2.25%
EPS NY rev (3m)2.79%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)1.45%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE 29.11
Fwd PE 22.03
P/S 1.27
P/FCF 43.3
P/OCF 33.88
P/B 5.85
P/tB N/A
EV/EBITDA 21.99
EPS(TTM)5.57
EY3.44%
EPS(NY)7.36
Fwd EY4.54%
FCF(TTM)3.74
FCFY2.31%
OCF(TTM)4.79
OCFY2.95%
SpS128.06
BVpS27.74
TBVpS-2.16
PEG (NY)1.33
PEG (5Y)4.4
Profitability
Industry RankSector Rank
ROA 3.94%
ROE 13.21%
ROCE 9.52%
ROIC 6.77%
ROICexc 7.28%
ROICexgc 14.04%
OM 4.26%
PM (TTM) 2.86%
GM 19.42%
FCFM 2.92%
ROA(3y)5.07%
ROA(5y)5.54%
ROE(3y)13.78%
ROE(5y)14.7%
ROIC(3y)7.46%
ROIC(5y)7.57%
ROICexc(3y)8.16%
ROICexc(5y)8.57%
ROICexgc(3y)18.67%
ROICexgc(5y)19.47%
ROCE(3y)9.51%
ROCE(5y)9.85%
ROICexcg growth 3Y-10.49%
ROICexcg growth 5Y-5.25%
ROICexc growth 3Y-6.39%
ROICexc growth 5Y-5.52%
OM growth 3Y-8.91%
OM growth 5Y-5.18%
PM growth 3Y-25.78%
PM growth 5Y-12.79%
GM growth 3Y-4.04%
GM growth 5Y-2.06%
F-Score6
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 6.64
Debt/EBITDA 3.11
Cap/Depr 43.42%
Cap/Sales 0.81%
Interest Coverage 3.6
Cash Conversion 60.88%
Profit Quality 102.2%
Current Ratio 1.13
Quick Ratio 1.13
Altman-Z 3.59
F-Score6
WACC9.6%
ROIC/WACC0.71
Cap/Depr(3y)45.67%
Cap/Depr(5y)46.01%
Cap/Sales(3y)0.89%
Cap/Sales(5y)0.91%
Profit Quality(3y)86.59%
Profit Quality(5y)117.01%
High Growth Momentum
Growth
EPS 1Y (TTM)50.95%
EPS 3Y-1.88%
EPS 5Y6.61%
EPS Q2Q%46.91%
EPS Next Y21.9%
EPS Next 2Y20%
EPS Next 3Y18.89%
EPS Next 5Y18.49%
Revenue 1Y (TTM)14.96%
Revenue growth 3Y8.83%
Revenue growth 5Y8.4%
Sales Q2Q%16.24%
Revenue Next Year12.55%
Revenue Next 2Y11.32%
Revenue Next 3Y10.72%
Revenue Next 5Y8.64%
EBIT growth 1Y26.13%
EBIT growth 3Y-0.86%
EBIT growth 5Y2.79%
EBIT Next Year56.39%
EBIT Next 3Y24.27%
EBIT Next 5Y17.91%
FCF growth 1Y116.68%
FCF growth 3Y-13.36%
FCF growth 5Y8.54%
OCF growth 1Y75.25%
OCF growth 3Y-10.27%
OCF growth 5Y6.9%